Can We Exploit the Molecular Heterogeneity of Aggressive B Cell Lymphomas Into Effective New Therapies?

Daniel J. Landsburg, Brad S. Kahl

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	65-67
Number of pages	3
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	19
Issue number	2
DOIs	https://doi.org/10.1016/j.clml.2018.11.017
State	Published - Feb 2019

Access to Document

@article{cf1dc65d4f9c4936a00dab9f4f29cfd1,

title = "Can We Exploit the Molecular Heterogeneity of Aggressive B Cell Lymphomas Into Effective New Therapies?",

author = "Landsburg, {Daniel J.} and Kahl, {Brad S.}",

year = "2019",

month = feb,

doi = "10.1016/j.clml.2018.11.017",

language = "English",

volume = "19",

pages = "65--67",

journal = "Clinical Lymphoma, Myeloma and Leukemia",